1.The impact of genetic counseling on performance of prenatalcytogenetic diagnosis.
Sei Kwang KIM ; Yeoung Ho YANG ; Chan Ho SONG
Korean Journal of Obstetrics and Gynecology 1992;35(12):1742-1748
No abstract available.
Diagnosis*
;
Genetic Counseling*
2.Nocturnal Arterial Oxygen Saturation Monitoring in Patients with Respiratory Disease.
In Seon CHOI ; Jae Beom YANG ; Young Chul KIM ; Ik Joo CHUNG ; Yu Ho KANG ; Yeoung Il KOH ; Sang Seon PARK ; Min Su LEE ; Kyung Ok PARK
Tuberculosis and Respiratory Diseases 1994;41(2):103-110
To find out the predictors of nocturnal arterial oxygen desaturation in patients with respiratory diseases, transcutaneous oxygen saturation(StcO2) monitoring studies using a pulse oximeter were performed during sleep in 20 patients. StcO2 was decreased more than 4% from the baseline value in 18 patients(90%) and more than 10%('Desaturator') in 8(40%). Five of the seven patients(71.4%) with awake PaO2<60mmHg and three of the thirteen patients(23.1%) with awake PaO2≥60mmHg were 'desaturators'. The awake PaO2/FIO2 and PaO2/PAO2 could distinguish 'desaturator' from 'nondesaturator, and PaO2, SaO2 or StcO2 could not. These results suggest that the nocturnal oxygen desaturation depends on the severity of the underlying disease rather than the baseline PaO2. Anthropomorphic and lung function factors could not separate between 'desaturator' and 'non-desaturator', and about a quarter of patients with a wake PaO2≥60mmHg developed significant desaturation. Therefore, it is necessary to monitor the nocturnal arterial oxygen saturation in patients with respiratory diseases regardless of their severity of airflow obstruction or awake PaO2.
Humans
;
Lung
;
Oxygen*
3.A case of Turner's syndrome with immature teratoma.
Min Kyung KIM ; Yeoung Yang PARK ; Hae Sook KIM ; Sang Yoon PARK ; Ja June JANG ; Je Ho LEE ; Eui Don LEE ; Kyung Hee LEE ; Kee Bok PARK
Korean Journal of Obstetrics and Gynecology 1991;34(9):1343-1347
No abstract available.
Teratoma*
;
Turner Syndrome*
4.A Case of Vanishing Bile Duct Syndrome Associated with Hypersensitivity to Allopurinol.
Seong Ho CHOI ; Soo Hyun YANG ; Young Bong SONG ; Hye Jin KIM ; Yeoung Tae SEO ; Dong Seog CHOI ; Kyoung Hyoub MOON ; Jong Hoon BYUN ; Eun Sil YU
The Korean Journal of Hepatology 2005;11(1):80-85
Allopurinol is frequently used for the treatment of hyperuricemia and gout. Sometimes, a life-threatening reaction develops, as is illustrated by the following case report. We describe a 60-year-old male patient who was treated with allopurinol because of asymptomatic hyperuricemia, and he was presented with fever, skin rash, eosinophilia, worsening renal function and vanishing bile duct syndrome. In this report, we discussed vanishing bile duct syndrome as a serious side effect of allopurinol, and we briefly reviewed the etiology, prevention, and treatment modalities for vanishing bile duct syndrome.
Allopurinol/*adverse effects
;
Bile Duct Diseases/*etiology/pathology
;
Drug Hypersensitivity/*complications
;
English Abstract
;
Gout Suppressants/*adverse effects
;
Humans
;
Male
;
Middle Aged
5.Two Cases of Broncholith Removal under the Guidance of Flexible Bronchoscopy.
Ka Yeoung YI ; Ho Kyeong LEE ; Seoung Ju PARK ; Yong Chul LEE ; Yang Keun RHEE ; Heung Bum LEE
The Korean Journal of Internal Medicine 2005;20(1):90-91
Most broncholiths are related to infection with fungus or tuberculosis and they involve the lymph nodes; those cases that are caused by silicosis are rarely seen. Broncholith might lead complication such as bronchial rupture into the mediastinum, which can result in hemoptysis, cough, repeated pneumonia and so on. Flexible bronchoscopy plays an important part in the diagnosis of broncholithiasis, but its therapeutic application in the clinical setting is controversial. We report here on two cases of broncholith removal without complication with the use of a balloon catheter and tripod forceps using flexible bronchoscopy.
Adult
;
Aged
;
*Balloon Dilatation
;
Bronchial Diseases/*therapy
;
*Bronchoscopy
;
Calculi/*therapy
;
Female
;
Humans
;
Male
6.Phase II Study to Topotecan and Cisplatin in Advanced Hepatocellular Carcinoma.
Ga Young LEE ; Bong Seog KIM ; Yeoung Tae SEO ; Seong Ho CHOI ; Hye Jin KIM ; Dong Seog CHOI ; Ji Young KO ; Soo Hyun YANG ; Jong Hoon BYUN
The Korean Journal of Internal Medicine 2003;18(2):104-108
BACKGROUND: Hepatocellular carcinoma remains a highly chemoresistant neoplasm and is a common malignancy with poor prognosis in Korea. We performed a phase II study to evaluate the efficacy and toxicities of topotecan and cisplatin combination chemotherapy for advanced hepatocellular carcinoma. METHODS: Between November 1999 and May 2001, ten patients with histologically proven hepatocellular carcinoma were enrolled in this study. The median age was 54 (range: 53~74) years and all were male. Six patients demonstrated stage IV, 1 stage IIIC, 2 stage IIIB and 1 stage IIIA. Six patients showed a ECOG performance status of 1. The treatment regimen consisted of topotecan 1.25 mg/m2 and cisplatin 20 mg/m2 for 5 days. The treatment was repeated every 4 weeks. Toxicities were evaluated according to WHO toxicity criteria. RESULTS: All ten patients were evaluable for response and toxicity. There was only one patient who achieved partial response. The overall response rate was 10% (95% C.I.) and the response duration was 46 weeks. The median survival of all patients was 21 (range: 17~54+) weeks. During a total of 24 cycles, neutropenia of WHO grade 3 and 4 occurred in 33%, thrombocytopenia in 33% and anemia in 21%. In non-hematologic toxicity, diarrhea and hepatoxicity of grade 3 occurred in 1 and 2 patients, respectively. But there was no treatment-related death. CONCLUSION: When used in this dose and schedule, topotecan and cisplatin combination chemotherapy does not seem to be effective for patients with advanced hepatocellular carcinoma.
Aged
;
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
;
Carcinoma, Hepatocellular/*drug therapy
;
Cisplatin/*administration & dosage
;
Human
;
Liver Neoplasms/*drug therapy
;
Male
;
Middle Aged
;
Topotecan/*administration & dosage
;
Treatment Outcome
7.The current changing trend for termination of pregnancy(1993-2000).
Ji Eun KIM ; Jung Yeol HAN ; Dong Chul OH ; Yon Ju KIM ; Young Chul CHUNG ; Sang Hee JUNG ; June Seek CHOI ; So Yeon PARK ; Hyun Kyong AHN ; Min Jeong OH ; Hyun Mee RYU ; Moon Young KIM ; Kyu Hong CHOI ; Yeoung Ho LEE ; Jae Hyug YANG
Korean Journal of Obstetrics and Gynecology 2001;44(11):2025-2030
OBJECTIVE: To evaluate the recent trend of indication for pregnancy termination. METHOD: From 1993 to 2000, 1,087 cases of termination out of 61,842 cases of deliveries in Samsung cheil hospital were analyzed. We reviewed retrospectively the data-base and charts of delivery, and analyzed the indication for pregnancy termination. RESULTS: Among 61,842 cases of deliveries, indications of pregnancy termination were fetal structure anomalies in 399 cases (0.7%), IUFD in 261 cases (0.4%), PROM in 215 cases (0.4%), chromosomal anomalies in 138 cases (0.2%), anhydroamnios in 32 cases (0.05%), rubella infection of mother or fetus in 24 cases (0.04%), and others in 20 cases (0.03%). Autopsy was performed in 242 cases of fetal anomalies (60.7%), 116 cases of UIFD (44%), and 59 cases of fetal chromosomal abnormalities (43%). The cases of chromosomal anomaly as indication of termination increased and rubella infection of mother or fetus decreased recently, and it is statistically significant r=0.95(P=0.00) and r=-0.73(P=0.04). The fetal weight terminated due to PROM is significantly decreased (Y=517-26 x year P=0.002). CONCLUSION: The indications of termination for fetal chromosomal abnormalities were increased, but for rubella infections were decreased. In cases of PROM, the terminated fetal weight were significantly decreased. However, no change was observed in cases of fetal anomaly, IUFD,and PROM.
Autopsy
;
Chromosome Aberrations
;
Fetal Weight
;
Fetus
;
Humans
;
Mothers
;
Pregnancy
;
Retrospective Studies
;
Rubella
8.Multi-center study for the utilization of quality of life questionnaire for adult Korean asthmatics (QLQAKA).
Jung Won PARK ; You Sook CHO ; Soon Yeoung LEE ; Dong Ho NAHM ; Yoon Keun KIM ; Dong Kee KIM ; Jee Woong SOHN ; Jae Kyung PARK ; Young Koo JEE ; Young Joo CHO ; Ho Joo YOON ; Mi Kyeong KIM ; Hae Sim PARK ; Byoung Whui CHOI ; In Seon CHOI ; Choon Sik PARK ; Kyung Up MIN ; Hee Bom MOON ; Sung Hak PARK ; Yang Keun LEE ; Nung Soo KIM ; Chein Soo HONG
Journal of Asthma, Allergy and Clinical Immunology 2000;20(3):467-480
BACKGROUND AND OBJECTIVE: Assessment of quality of life (QOL) of patients with chronic illness requires reasonable tools which reflect the patients' cultural and behavioral properties. We developed the quality of life questionnaire for adult Korean asthmatics (QLQAKA) on the basis of the Korean life style and evaluated its reliability and validity. METHODS: The QLQAKA consisted of four domains; symptoms (six items), daily activity (five items), emotion (three items) and reaction to environmental stimuli (three items). Patients answered each item according to a five-response scale. The reproducibility and validity of the questionnaire was estimated from the responses of 244 patients who visited the clinics in 15 institutes within a 2-week interval. RESULTS: Items with the most frequent complaints were dyspnea (87%), difficulty in sputum discharge or throat clearing (87%), limitation in strenuous activity (84%) and coughing (82.4%). The QLQAKA reflected the changes of patients' status very well. The value of minimal important differences, such as the clinically significant minimal change in the QOL score, was 0.5. The questionnaire was also highly reproducible with the value of intraclass correlation coefficiency and intraclass standard deviation as 0.940 (p<0.001) and 0.180, respectively. The changes of mean total QLQAKA score correlated weakly with the changes of FEV1 and PEFR values. CONCLUSION: The adult version of QLQAKA was valid and may be a reproducible tool for evaluating and monitoring Korean adult asthma patients.
Academies and Institutes
;
Adult*
;
Asthma
;
Chronic Disease
;
Cough
;
Dyspnea
;
Humans
;
Life Style
;
Peak Expiratory Flow Rate
;
Pharynx
;
Quality of Life*
;
Reproducibility of Results
;
Sputum
;
Surveys and Questionnaires